TY - JOUR
T1 - RGS16 is a marker for prognosis in colorectal cancer
AU - Miyoshi, Norikatsu
AU - Ishii, Hideshi
AU - Sekimoto, Mitsugu
AU - Doki, Yuichiro
AU - Mori, Masaki
PY - 2009/12
Y1 - 2009/12
N2 - Background: The RGS family, comprising 22 homologues of proteins, plays a role in cellular proliferation, differentiation, membrane trafficking, and embryonic development through the involvement of the mitogen-activated protein kinase signaling pathway. Methods: In order to demonstrate the importance of RGS16 expression for the prediction of prognosis of colorectal cancer (CRC), we analyzed RGS16 gene expression in 22 human gastrointestinal cell lines and 124 paired cases of CRC and noncancerous regions. Results: RGS16 was expressed in 17 human gastrointestinal cancer cell lines examined in this study. RGS16 expression was higher in colorectal cancer tissue than in corresponding normal tissue (P < 0.001) in messenger RNA (mRNA) and protein levels. Patients in the RGS16 high-expression group showed a poorer overall survival rate than those in the low-expression group (P < 0.001), indicating that high RGS16 expression was an independent prognostic factor. Conclusion: The present study suggests that RGS16 is useful as a predictive marker for patient prognosis of CRC.
AB - Background: The RGS family, comprising 22 homologues of proteins, plays a role in cellular proliferation, differentiation, membrane trafficking, and embryonic development through the involvement of the mitogen-activated protein kinase signaling pathway. Methods: In order to demonstrate the importance of RGS16 expression for the prediction of prognosis of colorectal cancer (CRC), we analyzed RGS16 gene expression in 22 human gastrointestinal cell lines and 124 paired cases of CRC and noncancerous regions. Results: RGS16 was expressed in 17 human gastrointestinal cancer cell lines examined in this study. RGS16 expression was higher in colorectal cancer tissue than in corresponding normal tissue (P < 0.001) in messenger RNA (mRNA) and protein levels. Patients in the RGS16 high-expression group showed a poorer overall survival rate than those in the low-expression group (P < 0.001), indicating that high RGS16 expression was an independent prognostic factor. Conclusion: The present study suggests that RGS16 is useful as a predictive marker for patient prognosis of CRC.
UR - http://www.scopus.com/inward/record.url?scp=71549128693&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=71549128693&partnerID=8YFLogxK
U2 - 10.1245/s10434-009-0690-3
DO - 10.1245/s10434-009-0690-3
M3 - Article
C2 - 19760045
AN - SCOPUS:71549128693
SN - 1068-9265
VL - 16
SP - 3507
EP - 3514
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 12
ER -
